InterVenn Biosciences Expands Board of Directors with Dr. Jason Myers and Carol Berry to Support Next Phase of Growth
InterVenn Biosciences announced the appointment of Jason Myers, Ph.D., and Carol Berry to the company’s Board of Directors.
Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
CIRM Grant of $6.85 million supports the first-in-human clinical study evaluating the safety and efficacy of EBT-101 in participants people living with HIV
Xendee Integrates UtilityAPI for Easier, Faster and More Precise Energy Load Modeling
The integration maximizes the efficiency of downloading past building load data directly from the utility, which gives engineers a more accurate view of past usage and peak requirements of their project.
Niron Magnetics Expands Management Team with Three Key Technology and Operations Hires
Experts in materials science, engineering, and operations will help Niron commercialize the world’s first high performance rare-earth free permanent magnets
Anzu Partners Welcomes Donald Rosenberg as Venture Partner
Rosenberg will work with portfolio companies as they develop their intellectual property strategies and more broadly support the next generation of transformative technology companies.
BioXpedia A/S and BioSkryb Genomics Announce European Partnership to Provide Groundbreaking, Single-Cell, Multiomic Analysis for Novel Target Identification and Therapeutic Development
This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in targeted disease management.
Introducing the GelSight Mini: A Human Resolution Tactile Sensor for Engineers and Scientists
GelSight Mini enables an enhanced AI-enabled tactile experience for users in just five minutes out of the box.
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-Cell Receptors
ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics announced that it has raised $14M in new financing.
Xendee Releases New Features for Effectively Designing Sustainable Communities, Large Facilities, and Utility-Scale Microgrids
Xendee’s optimization software even takes into account cable length, losses through transferring energy, and the most efficient ways to generate and distribute energy from multiple energy sources at all hours of the day.
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Excision BioTherapeutics announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1).